{"id":"W2042242996","doi":"10.1016/j.coph.2005.04.001","title":"Life after PDE4: overcoming adverse events with dual-specificity phosphodiesterase inhibitors","year":2005,"lang":"en","type":"review","venue":"Current Opinion in Pharmacology","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Phosphodiesterase; Roflumilast; Medicine; Phosphodiesterase 3; Adverse effect; Asthma; Pulmonary disease; Clinical trial; Pharmacology; Limiting; Intensive care medicine; Bioinformatics; Internal medicine; Enzyme; Chemistry; Biology; Biochemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000241006,0.000659574,0.0009487476,0.0002732102,0.00009034013,0.00001291213,0.0002067823,0.0004870626,0.0003195057],"category_scores_gemma":[0.00003741701,0.0005523951,0.0003507052,0.0002839166,0.0001329723,0.00001999458,0.0002433029,0.0005825147,0.00008317923],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001936899,"about_ca_system_score_gemma":0.0005148022,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003841833,"about_ca_topic_score_gemma":0.000006979571,"domain_scores_codex":[0.9971213,0.0003707616,0.0008739429,0.0008989403,0.0002304955,0.0005045905],"domain_scores_gemma":[0.9987268,0.00004710439,0.0004829059,0.0003526176,0.00008661793,0.0003039657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001790743,0.001547353,0.001935648,0.01195518,0.0006723606,0.00002510699,0.000187249,0.0003116674,0.0001516868,0.00002054808,0.0911386,0.8902639],"study_design_scores_gemma":[0.001573785,0.0001417212,0.0001590402,0.002871658,0.0001793826,0.00004385181,0.00001241703,0.00001752963,0.00009812082,0.000001726445,0.9942875,0.0006132771],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001930207,0.9825898,0.0001310392,0.00006081072,0.01399842,0.00110518,0.0001036128,0.00003151427,0.00004936351],"genre_scores_gemma":[0.001026952,0.993311,0.00006601724,0.0001495379,0.003475219,0.0005922265,0.001097694,0.00007900016,0.0002023616],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9031489,"threshold_uncertainty_score":0.9996927,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04772506309881403,"score_gpt":0.3705159320219377,"score_spread":0.3227908689231237,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}